{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T02:53:29Z","timestamp":1781319209759,"version":"3.54.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.leukres.2009.01.036","type":"journal-article","created":{"date-parts":[[2009,2,28]],"date-time":"2009-02-28T04:37:32Z","timestamp":1235795852000},"page":"1137-1140","source":"Crossref","is-referenced-by-count":44,"title":["Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?"],"prefix":"10.1016","volume":"33","author":[{"given":"E.","family":"Katodritou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Gastari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Verrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hadjiaggelidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Varthaliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Georgiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Laschos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Xirou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Yiannaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Constantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Markala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zervas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.01.036_bib1","first-page":"609","volume":"87","author":"Alegre","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2009.01.036_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/10428190310001617231","article-title":"Possible multiple myeloma dedifferentiation following thalidomide therapy: a report of four cases","volume":"45","author":"Balleari","year":"2004","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.leukres.2009.01.036_bib3","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1365-2141.2002.03513.x","article-title":"Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma","volume":"117","author":"Sahara","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.01.036_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3324\/haematol.10297","article-title":"Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chains","volume":"92","author":"Dawson","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2009.01.036_bib5","first-page":"832","article-title":"Extramedullary myeloma escapes the effect of thalidomide","volume":"89","author":"Rosinol","year":"2004","journal-title":"Haematological"},{"key":"10.1016\/j.leukres.2009.01.036_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJM199003083221005","article-title":"Markers of multiple hematopoietic-cell lineages in multiple myeloma","volume":"322","author":"Epstein","year":"1990","journal-title":"N Engl J Med"},{"issue":"July (1)","key":"10.1016\/j.leukres.2009.01.036_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0609.2006.00661.x","article-title":"Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma","volume":"77","author":"Sahara","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2009.01.036_bib8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2141.1994.tb05115.x","article-title":"Expression and functional role of c-kit ligand (SCF) in human multiple myeloma","volume":"88","author":"Lemoli","year":"1994","journal-title":"Cells Br J Haematol"},{"key":"10.1016\/j.leukres.2009.01.036_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2141.2003.04260.x","article-title":"CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high-risk disease","volume":"121","author":"Guikema","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.01.036_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2141.2003.04783.x","article-title":"CD27-triggering on primary plasma cell leukaemia cells has anti-apoptotic effects involving mitogen activated protein kinases","volume":"124","author":"Guikema","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.01.036_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.leukres.2007.04.016","article-title":"Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: first reported case","volume":"32","author":"Katodritou","year":"2008","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2009.01.036_bib12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.leukres.2007.11.010","article-title":"Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?","volume":"32","author":"Katodritou","year":"2008","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2009.01.036_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000112217","article-title":"Unusual discordant responses in two multiple myeloma patients during bortezomib treatment","volume":"31","author":"Pirrotta","year":"2008","journal-title":"Onkologie"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609000538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609000538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T04:56:01Z","timestamp":1545368161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0145212609000538"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.01.036","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}